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Objective: evaluate the practicality, acceptability and the floor and ceiling effects, estimate the 
reliability and verify the convergent construct’s validity with the instrument called the Heart 
Valve Disease Impact on daily life (IDCV) of the valve disease in patients with mitral and or aortic 
heart valve disease. Method: data was obtained from 86 heart valve disease patients through 
3 phases: a face to face interview for a socio-demographic and clinic characterization and then 
other two done through phone calls of the interviewed patients for application of the instrument 
(test and repeat test). Results: as for the practicality and acceptability, the instrument was 
applied with an average time of 9,9 minutes and with 110% of responses, respectively. Ceiling 
and floor effects observed for all domains, especially floor effect. Reliability was tested using the 
test - repeating pattern to give evidence of temporal stability of the measurement. Significant 
negative correlations with moderate to strong magnitude were found between the score of the 
generic question about the impact of the disease and the scores of IDCV, which points to the 
validity of the instrument convergent construct. Conclusion: the instrument to measure the 
impact of valve heart disease on the patient’s daily life showed evidence of reliability and validity 
when applied to patients with heart valve disease.
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Introduction
Chronic disease may begin as an acute condition 
and extending through episodes of exacerbation and 
remission of symptoms. While it is possible to control 
the accumulation of events, the constraints imposed 
by the treatment can lead to a drastic change in the 
lifestyle of the subjects (1-2). Among the chronic diseases 
that evolve with these features, the cardiovascular 
disease (CVD), is an important cause of morbidity and 
mortality in the context of global health(3). In Brazil, in 
2013, cardiovascular diseases were the leading cause 
of death among all other conditions, corresponding to 
28.0 % of the proportion of deaths with defined causes, 
wit acute myocardial infarction (AMI) being the cause 
of death of 85,939 people, and of these, 40,366 from 
the Southeast region. It is worth to highlight that in 
June 2015 alone, ischemic heart disease accounted for 
2.3% of total admissions by the Brazilian Unified Health 
System(4).
Valve disease in Brazil, represents a significant 
portion of hospitalizations for CVD. Rheumatic fever 
is the main cause of valve disease in the national 
context, responsible for up to 70% of cases, unlike 
what happens in developed countries. However, national 
data on rheumatic fever, obtained through DATASUS, 
refer to the number of hospitalizations and valvular 
interventions, which may underestimate the actual 
number of cases, since it does not include heart valve 
disease patients diagnosed in the outpatients’ clinic and 
that did not required hospitalization(4-5). The patient with 
valve disease may have different signs and symptoms 
(pain, fatigue, arrhythmia, palpitations, syncope, 
weariness and angina) whose frequency and intensity 
are associated with the valve apparatus affected, being 
the mitral or aortic valve , the type of injury (stenosis or 
insufficiency) and the stage of evolution of the valvular 
heart disease(5). Due to the slow and progressive nature 
of many of these lesions, patients may not recognize the 
symptoms, since the limitation of their daily activities 
also occur gradually(6).
The symptoms experienced by these patients 
result in changes in physical function, self-esteem, 
body image, social relations and a number of daily 
activities(7-8). Therefore, nurses should include in the 
care of these patients, not only biological aspects, but 
also those related to psychosocial variables, helping to 
overcome its limitations and the acquisition of coping 
mechanisms(9).
In order to support nursing interventions that 
minimize the impact of valvular disease in the life of the 
subject, a specific instrument to measure the perception 
of valvular disease on the impact of the disease in his life, 
called “Heart Valve Disease Impact on daily life - IDCV”, 
built and validated by the Brazilian cultural context(10-11).
This instrument showed reliable and valid 
psychometric properties when applied to valvular disease 
patients(11). Although the instrument has been developed 
to be used with these patients, the refinement of its items 
resulted in the selection of issues that were pertinent 
to the impact assessment of valvular heart disease and 
also to assess the impact on other heart diseases with 
similar symptoms. In previous studies performed(12-15) 
the reliability and validity of the instrument were shown, 
when applied in patients with coronary artery disease, 
heart failure and hypertension (AHT). A broader study 
was designed to assess the responsiveness of the 
instrument when applied to valvular disease patients 
and cardiac patients undergoing surgery(16).
However, considering the psychometric evaluation 
of the performance of IDCV with patients with valvular 
disease, there was no estimation of the reliability of the 
instrument with regard to the stability of measurement, 
just as the occurrence of ceiling and floor effects. 
Moreover, it was considered important to investigate 
the construct convergent validity through correlational 
evidence with a general question regarding the impact 
of the disease constructed by the authors of IDCV. 
Thus, this study aimed to: assess the feasibility, 
acceptability and ceiling and floor effects; estimate the 
reliability with respect to the stability of the measure 
and verify the convergent construct validity of the Heart 
Valve Disease Impact on daily life mitral valve disease 
and / or aortic outpatients at a university hospital. 
The results of this study contribute to the 
psychometric refinement of an instrument built in 
the Brazilian culture in order to measure the impact 
of valvular disease in subjects’ lives. The availability 
of a reliable, valid and robust tool can guide health 
professionals in the development of more effective 
behaviors to minimize the impact of disease on daily life 
of these patients.
Methods
Type of study
This is a methodological instrument validation study 
to measure the impact of the disease - the IDCV(17).
Study Location
The study was conducted in the cardiology 
outpatient clinic - subspecialty valvular disease - of a 
large university hospital in the interior of São Paulo 
State.
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Subjects and Sample Size
This study included patients with mitral and / or 
aortic valve disease, of both sexes, aged over 18 years, 
subject to clinical and / or surgical treatment, in the 
aforementioned outpatient clinic. Patients who presented 
inability for effective verbal communication due to 
neurological or psychiatric changes were excluded.
The size of the sample followed the recommendations 
of validation studies, i.e., 100 subjects(18). However, 
due to losses in the data collection stage, especially in 
the repeat test step, the final sample consisted of 86 
patients.
Data Collection
Data was collected through personal interviews 
carried out individually by the researcher to obtain 
socio-demographic and clinical data, and by telephone 
to obtain data on the impact of the disease through the 
application of IDCV. The following data collection steps 
were established:
- First step: the initial approach to clarify the 
objectives of the study and obtain the patient’s 
consent to participate by signing the Terms of Free 
and Informed Consent (TFIC). The patients were 
instructed that their participation in the study would 
involve a questionnaire through two telephone contacts. 
Obtaining consent, it used the data recording method 
available to obtain information from medical records on 
the socio-demographic and clinical characterization of 
subjects studied. Further, through structured interview 
techniques were obtained socio-demographic and clinic 
data, not available in the clinical hospital records;
- Second step: We performed the first telephone 
contact for the application of IDCV (test);
- Third step: 7 to 22 days after the first application 
of IDCV (test) a new telephone contact was conducted 
for the second application of this instrument (repeat 
test). The interval between the test and repeat testing 
was determined in accordance with the recommendation 
that the period between applications should not be 
too short, - to prevent the memory of the responses 
provided in the first interview - not too long, since 
the occurrence of other events in the daily lives of 
patients could explain the variations identified in the 
scores(19). It is noteworthy that the implementation of 
IDCV through telephone contact was chosen, because 
of the difficulties of the participants attending the 
second time of application of IDCV (repeat test). The 
literature recommendations for the use of the telephone 
contact in data collection were followed. In this sense, 
it was evidenced an invariance in performance scales 
used in different application groups - in person or by 
phone, suggesting that telephone contact is a reliable 
strategy to obtain data when compared to face-to-face 
interview, in addition to being effective, inexpensive and 
accessible(20). Thus, in this study the IDCV applications 
in the test and repeat test were conducted by telephone 
contact in order to maintain the same method of data 
collection and avoid bias collection, thus ensuring the 
accuracy in obtaining these data.
Data Collection Instruments
- Socio-demographic and clinical instrument: It 
was used an instrument built and submitted to content 
validity(21 );
a) Socio-Demographic Data: to obtain data such 
as: name initials, age, registration number in the chart, 
gender, education, marital status, employment, with 
whom they live, family and individual monthly income;
b) Clinic Characterization: Individuals data were 
collected for signs and symptoms that occurred during 
the month immediately prior to the collection and by 
consulting the records, information was obtained about 
the date of diagnosis of valvular heart disease, type of 
valve disease, treatment data (medical or surgical) and 
medicines in use.
- Heart Valve Disease Impact on daily life (IDCV)
(10-11): developed and validated in order to evaluate the 
impact of valve disease in the patient’s life. This is an 
instrument consisting of two scales (A and B). Part A 
has items with statements regarding the impact, and 
Part B items assessing each of the consequences listed 
in Part A, for a total of 14 items. The items are grouped 
into four factors or domains: Physical impact of the 
disease - symptoms- (Items 11, 12 e 13); Impact of 
the disease on daily activities, (5, 7, 9, 10 and 14); 
Social and emotional impact of the disease, (Items 2, 
3, 4 e 6) and Adaptation to illness (1 and 8). In the first 
scale (Part A) the Likert response scale of five points is 
used, from (1) strongly disagree to (5) strongly agree. 
In Part B, which measures the assessment that the 
subject has on each result of valvular disease mentioned 
in the first scale (Whether it occurs or not in his/her 
life), the answers range from (1) very bad to (5) very 
good. To calculate the score, each item corresponds to 
the product of the scores obtained in Parts A and B of 
IDCV, generating a minimum score of 1 and a maximum 
of 25 for each statement evaluated. The closer the 
score is to 1, the lower the impact felt by the subject, 
and the closer it is to 25, the greater the impact. In 
Part A, which measures the intensity of agreement / 
disagreement with the statements, items 1, 5 and 8 for 
addressing the favorable impact perceptions, have their 
score inverted so that all statements can be assessed 
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in the same direction, therefore, the higher the score 
the greater the impact. In Part B, the scores of all items 
are reversed and, the lower the score, the better the 
evaluation that the patient makes of the affirmative. 
The final score of the measured impact is obtained by 
summing all the products, with a possible variation score 
of 14-350. The lower the score, the less the patient 
perceives the negative consequences of the disease in 
his/her life evaluating them as bad. On the other hand, 
the higher the score, the more the patient recognizes 
the occurrence of the negative consequences of the 
disease in his life, and these consequences, in fact, are 
interpreted as negative.  The IDCV yet has a general 
question of impact assessment (which is not included in 
the calculation of the total score) - “When considering 
all the consequences of heart disease in your life, how 
do you assess the impact of the disease?” with scores 
ranging from 1. Very bad 2. Bad 3. Do not know the 
answer 4. Good and 5. Very good; the lower the score the 
greater the impact of the disease. In the present study, 
this question was considered a general measure of the 
impact of the disease and used to test the convergent 
construct validity of IDCV. Although IDCV was originally 
developed for evaluation of beliefs from valvular disease 
patients, it appears that the set of statements that 
compose it assesses the impact of chronicity imposed 
by different cardiovascular diseases(11). The instrument 
obtained satisfactory psychometric performance when 
applied in CAD  patients(12-13), those with heart failure(14), 
just as in hypertensive patients(15). 
Data Analysis
The psychometric properties of IDCV were assessed 
according to the criteria recommended by international 
literature(22). Data were entered into a spreadsheet 
(Excel Software, 2010) and transferred to SPSS - 
Statistical Package for Social Sciences, version 17.0 for 
Windows, for the following analysis:
- Descriptive: frequency tables, position 
measurements (mean, median, minimum and maximum) 
and dispersion (standard deviation) for data of socio-
demographic and clinical characterization instruments. 
The practicality of the IDCV was evaluated by the time 
for instrument application, and the time of the interview 
as clocked by researcher. The feasibility / acceptability 
was assessed by the percentage of unanswered items 
and the proportion of patients who did not respond to 
all items(22). To analyze the ceiling effect the percentage 
of patients who rated ceiling, i.e. 10% showing the 
highest scores IDCV (indicating greatest negative 
impact of disease)(23) was calculated, both for the total 
IDCV (≥316.4) as for its domains (physical impact of 
the disease - symptoms ≥67.8, impact of disease on 
daily activities ≥113.0, social and emotional impact of 
illness and adaptation ≥90.4 disease ≥45.2). It was 
also estimated the percentage of patients who rated 
floor(23), that is, showed 10% of the smallest possible 
scores IDCV (Therefore, the lowest scores, which means 
less impact - ≤10.2 symptoms, disease impact ≤17.0 
in daily activities, social and emotional impact of the 
disease ≤13.6 and adaptation to the disease ≤6.8). 
Ceiling and floor effects were considered moderate up to 
25% and substantial when higher than 25%(23).
- Reliability with regards to the agreement between 
repeated measurements (Test- repeat test) through 
the use of the intra-class correlation coefficient (ICC). 
Coefficient ICC > 0.70(24) was considered as evidence of 
measurement stability. 
- Convergent construct validity through the use 
of the Spearman correlation coefficient to verify the 
relationship between domain scores and total IDCV and 
the score obtained by applying the general question 
on the impact of the disease provided by IDCV “When 
considering all the consequences of heart disease in your 
life, how do you assess the impact of the disease”. The 
following criteria were used to classify the magnitude of 
correlations: Correlations <0.30 were considered of low 
magnitude, between 0.30 and 0.50 for moderate and> 
0.50 strong magnitude(25).
The significance level for the statistical tests was 
5%.
Ethical Aspects
The study was approved by the Ethics Committee 
of the local university through an addendum to broader 
project developed in the research group (Resolution nº 
843/2010). Patients involved signed the TFIC. 
Results
Socio-demographic and Clinical Characterization
Of the 86 participants, 58.1% were women, with a 
mean age of 52.7 (SD = 12.9) years, average schooling 
years of 6.4 (SD = 3.2) years; 55.8% were married, 
living with a spouse and children (41.9%), inactive 
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(47.7%), with average individual income of 1.9 (SD 
= 1.2) minimum wages (MW) and household income 
average of 2.9 (SD = 1.9) MW month.
Considering the clinical diagnosis, 37.2% of 
patients have a single lesion in a single valve device 
and 31.4% of subjects showed involvement of more 
than one valve apparatus. Fatigue (53.5%) and dyspnea 
(50%) were the most frequently reported symptoms. 
The median time from start of treatment was 14.1 (SD 
= 12.6) years. Most patients (71.3%) were in clinical 
treatment and had undergone surgical treatment. These 
patients consume an average of 4.4 (SD = 2.1) types of 
medication a day.
Analysis of the feasibility, acceptability and ceiling 
and floor effects of IDCV
All patients responded in full to all items of IDCV, 
pointing to high acceptability test in the sample. The 
practicability of IDCV assessed with patients with 
valvular heart disease, was tested by time spent in 
the application of the instrument, being observed an 
average time of 9.9 (SD = 3.3) minutes, ranging from 
4.7 to 27.1 minutes. The application time was measured 
by the researcher with the aid of a digital timer that 
allowed measurement of tenth of minutes.
Regarding the analysis of the ceiling and floor 
effects (Table 1), it is pointed out that 32.6% of patients 
scored in the floor area of Adaptation to the Disease and 
17.4% in the area called Physical Impact of the Disease 
- Symptoms. Regarding the ceiling effect, 11.6% of 
patients scored in 10% of the highest scores of the scale 
in the field of Physical Disease Impact - symptoms, i.e., 
scores indicating greater impact of the disease in the 
subject’s life.
Table 1 - Descriptive analysis and ceiling and floor effects of the instrument Heart Valve Disease Impact on daily life 
(IDCV) in heart valve disease patients (n=86) Campinas, SP, Brasil, 2012.
Field Items Average (dp) Median Amplitude DefinitionFloor effect*
Definition
Ceiling Effect†
Floor 
Effect (%)
Ceiling 
Effect (%)
IDCV‡ total 14 154.5 (70.4) 152.5 301.0
Scores Scores
8.1 1.2
≥316.4 ≤47.6
Physical Impact – symptoms 3 35.8 (21.6) 34.0 72.0
Scores Scores
17.4 11.6
≥67.8 ≤10.2
Disease’s Impact – Daily 
activities 5 62.3 (31.8) 65.5 120.0
Scores Scores
9.3 3.5
≥113.0 ≤17.0
Social and Emotional Impact of 
the disease 4 43.1 (25.2) 41.0 89.0
Scores Scores
12.8 1.2
≥90.4 ≤13.6
Adaptation to the Disease 2 13.4 (8.7) 11.0 34.0
Scores Scores
32.6 --
≥45.2 ≤6.8
*Floor effect equivalent to 10% of the lowest scale scores; †Ceiling effect equivalent to 10% of the highest scores of the scale; ‡IDCV - Heart Valve Disease 
Impact on daily life.
Reliability Analysis
To evaluate the reliability of the instrument we 
considered the criteria of temporal stability with use of 
test and repeat test. The total of 70 patients responded 
to the repeat test. It has been found adequate degree 
of agreement in the estimates of intra-class correlation 
coefficients (ICC) for the total IDCV and for most areas, 
and found less ICC in the field of Disease Impact on 
Daily Activities (ICC = 0.76), as shown in table 2.
Table 2 – Intra-class correlation coefficients (ICC) and 
confidence intervals (95% CI) of the instrument Heart 
Valve Disease Impact on daily life (IDCV) when applied 
to heart valve disease patients (n = 70). Campinas, SP, 
Brazil, in 2012.
IDCV* ICC CI‡ 95%
Physical Impact of the disease – symptoms. 0.77 0.67-0.86
Impact of the disease in daily activities. 0.85 0.79-0.92
Social and Emotional impact of the disease. 0.85 0.79-0.92
Adaptation to the disease. 0.81 0.73-0.90
IDCV Total. 0.91 0.87-0.95
*Heart Valve Disease Impact on daily life - IDCV; †ICC=Intra-class 
Correlation Coefficients; ‡CI=Confidence Intervals.
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Analysis of convergent construct validity
The results of the convergent construct validity 
assessed by the correlation between the total scores and 
the areas of IDCV and the scores of the general question 
on the assessment of the impact on subject’s life are 
presented in Table 3. 
Considering the assessment of the general question 
of the impact, the lower the score the higher the impact 
perceived by the subject and that the interpretation 
of the total score of IDCV the lower the score, the 
lower the impact perceived by the subject, statistically 
significant negative correlations were expected between 
variables analyzed. Negative significant correlations 
were found, moderate to strong magnitude between the 
measurement provided by the generic question about 
the impact of the disease and the total IDCV and most 
of its domains, except for the Adaptation to Disease 
that showed no correlation with the generic measure 
of impact. There was a significant correlation of strong 
magnitude between the scores of the general question of 
impact and the total IDCV (r = -0.5273), just as among 
the general measure and the field Social and Emotional 
Impact (r = -0, 5174) (Table 3).
Table 3 - Spearman correlation coefficients between the score of the generic question about the impact of disease 
and IDCV global and domains scores*. Campinas, SP, Brazil, in 2012.
Variables 1 2 3 4 5 6
IDCV* Physical – Symptoms. 1.0
IDCV  Daily Activities. 0.52† 1.0
IDCV  Social and Emotional. 0.48‡ 0.68‡ 1.0
IDCV  Adaptation to the disease. 0.22§ 0.36§ 0.30§ 1.0
IDCV  Total. 0.73‡ 0.90‡ 0.86‡ 0.46‡ 1.0
Generic Measure – Impact. -0.37§ -0.47‡ -0.52‡ -0.05† -0.53‡ 1.0
*Heart Valve Disease Impact on daily life - IDCV; †Not significant; ‡ p< 0,0001; §p≤0,0005;
Discussion
This study aimed to evaluate the feasibility, 
acceptability and ceiling and floor effects; estimating 
the reliability as regards the stability of the measure 
and verify validity of the convergent construct IDCV, 
when applied to patients with valvular heart disease as 
outpatients. 
The evaluation of practicability of the IDCV showed 
that it is a rapid implementation tool with an application 
average time of 9.9 minutes (SD = 3.3). This finding 
is consistent with those found in previous study (12), in 
which the average application time was 09 minutes, 
according to another study(15), the application of IDCV 
lasted 08 minutes. Regarding acceptability, all patients 
responded to all items, not being detected a score 3, 
which corresponds to the neutral response. Thus, the 
findings show that the IDCV proved easy to apply in the 
study group. 
In the present study we evaluated the ceiling effects, 
which may indicate involvement in the instrument’s 
ability to detect changes in health status with regard to 
the increase in perceived impact and thus, in situations of 
clinical worsening. Floor effect was detected suggesting 
impairment in the instrument’s ability to detect changes 
in situations where there is an improvement in health 
condition due to the reduced impact of the disease(23).
The analysis of data on ceiling and floor effects 
revealed a moderate ceiling effect in the domain 
Physical Impact of Disease – symptoms and substantial 
floor effect on the domain Adaptation to disease and 
moderate in other areas of scale, especially in the 
domains Physical Impact of Disease - Symptoms and 
Impact social and Emotional disease. 
In other studies of IDCV, it was also observed floor 
effect in the areas of Physical Impact of the Disease 
– symptoms and in the field of Social and Emotional 
Impact(12,15). In a study by Santos et al.(12), 49.0% of 
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patients scored in the floor area of Adaptation to the 
disease. However, contrary to the findings of the present 
study, in a previous study, 31.4% of patients scored 
ceiling in the same domain(15). These findings can be 
explained in part by the constitution of their items: Item 
1 “After I got heart troubles, did I start to pay more 
attention to my health?” And Item 8 “Is my sex life the 
same as before the heart problem?” which can cause 
double interpretation. Respondents can interpret item 
1 as a good or bad result and in item 8 understanding 
its difficulty may be related to the assessment of the 
consequences of the disease in sexual life, since the 
individual may not have any information about the 
quality of life sexual before the disease. 
Another assessed property was the reliability of the 
instrument by the criteria of temporal stability by using 
the test- repeat test. We sought to assess whether in a 
given time interval, the participants’ answers to IDCV 
showed little variation in the absence of external factors 
that could affect the perception of the subject on the 
concept studied(15). In the present study the temporal 
stability was investigated in the interval of 7 to 22 days, 
by telephone contact, a strategy previously used(20). 
An appropriate level of agreement has been found 
between test / repeat test for total IDCV and for most 
areas, with the lowest value of ICC found in the field 
of disease impact on daily activities (ICC = 0.76). 
These results coincide with those obtained in previous 
studies(14-15). In the study among patients with heart 
failure we observed an ICC> 0.96 for most IDCV fields 
except for the field Adaptation to the Disease(14). In the 
study involving patients with AHT it has been found an 
ICC> 0.99 for the total IDCV, as well as their domains(15). 
These results point to the reliability of IDCV when applied 
to different samples of patients with cardiovascular 
diseases.
Considering that the results of this study with regard 
to testing and repeat testing are mostly similar to other 
IDCV validation studies, it may be considered that the 
investigation of the measure stability by phone does not 
interfere with the quality of the findings. However, it is 
recommended to carry out new studies, with expansion 
of the sample in order to contribute to building evidence 
for the application of the test and repeat test by phone. 
As per previous hypothesis, significant negative 
correlations were found between the extent provided by 
general question of burden of disease and the total IDCV 
and most of its domains, suggesting convergent validity. 
Construct validity estimates the extent to which the 
scores of a measuring instrument are consistent with 
hypotheses derived from the concept in measurement. 
It aims to validate an underlying body of theory as a 
measurement, and test the hypothetical relations 
presupposed in this theoretical body(17,24). It seems there 
is no consensus on the number of hypotheses to be 
verified to ensure adequate validity (26). The convergent 
construct validity in turn, relates to the correlation 
between similar constructs measures(24). According to 
Polit(27) in the absence of a gold standard, assumptions 
about the correlation between instrument scores and the 
scores of a measure with which is expected conceptual 
convergence, are tested. Therefore, the finding of a 
correlation between the total score of IDCV and the 
general question of the impact of the disease points 
to the fitness of its items to the concept that tries to 
measure, one of the important properties in measuring 
self-reported instruments.
The present study has limitations related to the 
small sample size and the fact of not having been 
employed other generic tools for assessing the impact 
of the disease on the patient’s life. Moreover, the 
generalization of the findings of this study is limited, since 
the survey was conducted in a sample of patients with 
valvular heart disease that were outpatients. However, 
this study adds important contributions to literature, 
since it collaborates in psychometric refinement of a 
tool with evidence of reliability and validity for the study 
of the impact of the disease, which may be useful in 
evaluating outcomes of nursing interventions, and at 
the same way it is contributing to the construction of 
evidence about the quality of test results and applying 
the repetition test by phone. 
It is suggested to carry out new studies aimed to 
investigate the responsiveness of IDCV in patients with 
different cardiovascular diseases.
Conclusion
This study concludes that the instrument to 
measure the Heart Valve Disease Impact on daily life  – 
IDCV is an instrument with good acceptability and easy 
to apply, but it found the need to review the items that 
make up the domain of adaptation to the disease. The 
analysis of the ceiling and floor effects points specifically 
to the occurrence of the floor effect in different areas 
of the instrument which may indicate a lower potential 
www.eerp.usp.br/rlae
8 Rev. Latino-Am. Enfermagem 2016;24:e2730.
of the IDCV to detect changes in clinical improvement 
of conditions. Reliability was demonstrated with 
respect to temporal stability and convergent construct 
validity with generic question of disease impact. The 
results of this study contribute to the refinement of 
the psychometric properties of IDCV in patients with 
different cardiovascular diseases. 
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